First Cool-Down Performance of the LHD

The first cool-down test of the Large Helical Device (LHD) and the performance of the LHD cryogenic system during the first cycle operation are described. The first cool-down started on Feb. 23, 1998 and finished on Mar. 22. After the cool-down, the excitation tests of the SC coils up to 1.5 T and the first cycle operations for plasma physics experiments were conducted until May 18. The first cycle operation was successfully completed after the warm-up process to room temperature from May 19 to Jun. 15. The cooling characteristics of the LHD, such as temperature distribution during cool-down, heat loads under steady state condition, reliability during long-term operation, are reporte

SmartPad: A Finger-Sensing Keypad for Mobile Interaction

This paper introduces SmartPad, a new input device for mobile computers that is an enhanced physical keypad by a finger position sensor. This input device acts as a normal keypad for mobile devices, such as cellular phones, and also recognizes finger position on the keypad be before the user presses the key. This feature is used to recognize finger gesture on the keypad, and can also be used to give preview information to the user before the user actually pressing the key. This previewable function helps users to predict the effect of the action, and it is also helpful when the key definitions are frequently changed according to the context, such as in the case of universal commanders

Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI:AMulticenter Study

Dementia with Lewy bodies (DLB) is one of the main etiologies of neurodegenerative dementia after Alzheimer’s disease (AD).1 Distinguishing DLB from AD is difficult because of their overlapping clinical and pathological features.2–4 Patients with clinically defined DLB may also have AD-type pathological changes as well as the characteristic Lewy bodies. However, the differential diagnosis is particularly important because DLB respond better to cholinesterase inhibitors but are sensitive to neuroleptics, which cause worsening of clinical status